Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 9/20 | 0.74 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.74 |
| ▸ | PKM | P14618 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.67 |
| ▸ | MEN1 | O00255 | 8/20 | 0.67 |
| ▸ | CASP6 | P55212 | 6/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | CASP3 | P42574 | 2/20 | 0.51 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1791394 | 0.86 | GAA (1.00) | GAATLR9PKMKMT2AMEN1 | |
| SCHEMBL2132967 | 0.81 | KMT2A (0.68) | GAAKMT2AMEN1HSP90AA1TDP1 | |
| SCHEMBL11867038 | 0.80 | GAA (1.00) | GAATLR9PKMKMT2AMEN1 | |
| SCHEMBL10561957 | 0.80 | GAA (0.76) | GAATLR9PKMKMT2AMEN1 | |
| SCHEMBL8995947 | 0.79 | HSP90AA1 (0.54) | GAATLR9PKMKMT2AMEN1 | |
| SCHEMBL23775711 | 0.77 | SCN2A (0.64) | GAAKMT2AMEN1HSP90AA1GFER | |
| SCHEMBL11839926 | 0.77 | KMT2A (0.73) | GAATLR9PKMKMT2AMEN1 | |
| SCHEMBL12037581 | 0.75 | GRM4 (0.55) | GAATLR9PKMKMT2AMEN1 | |
| SCHEMBL8965241 | 0.74 | HSP90AA1 (0.65) | KMT2AMEN1HSP90AA1TDP1HPGD | |
| SCHEMBL4695023 | 0.72 | GAA (0.67) | GAATLR9PKMKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2450348-B1 | NOVEL DIARYLAMINE COMPOUND, AND ANTI-AGING AGENT, POLYMER COMPOSITION, CROSSLINKED RUBBER PRODUCT AND MOLDED ARTICLE THEREOF, AND METHOD FOR PRODUCING DIARYLAMINE COMPOUND | ZEON CORP (JP) | 2016-12-14 | — | — | EP | disclosed |
| US-8883888-B2 | Diarylamine compounds, aging inhibitor, polymer composition, crosslinked rubber product and molded article of the crosslinked product, and method of producing diarylamine compound | ZEON CORPORATION (JP) | 2014-11-11 | — | — | US | disclosed |
| US-20120101196-A1 | NOVEL DIARYLAMINE COMPOUNDS, AGING INHIBITOR, POLYMER COMPOSITION, CROSSLINKED RUBBER PRODUCT AND MOLDED ARTICLE OF THE CROSSLINKED PRODUCT, AND METHOD OF PRODUCING DIARYLAMINE COMPOUND | ZEON CORPORATION (JP) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101196-A1 | NOVEL DIARYLAMINE COMPOUNDS, AGING INHIBITOR, POLYMER COMPOSITION, CROSSLINKED RUBBER PRODUCT AND MOLDED ARTICLE OF THE CROSSLINKED PRODUCT, AND METHOD OF PRODUCING DIARYLAMINE COMPOUND | CDKN1A, DDAH1, CCNI | GAA 3051/4885TLR9 4851/4885PKM 1775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.